Controls (n = 72) | AD (n = 92) | |
---|---|---|
Gender (male/female) | 16/56 | 32/60 |
Age (years) | 75 ± 7 | 76 ± 7a |
MMSE at baseline | 29 ± 2 | 19 ± 4b |
Body Mass Index (BMI) | 27 ± 5 | 24 ± 4b |
Arterial hypertension (yes/no) | 19/53 | 27/65 |
Diabetes mellitus (yes/no) | 6/66 | 9/83 |
Hyperlipidemia (yes/no) | 18/54 | 14/77 |
Atherosclerotic disease (yes/no) | 9/61 | 13/78 |
Previous stroke (yes/no) | 0/72 | 0/92 |
CSF tau | 95 ± 50 | 173 ± 97b |
CSF P-tau | 31 ± 18 | 130 ± 74b |
CSF Aβ42 | 260 ± 77 | 157 ± 41b |
CSF IGF-I | 0.60 ± 0.20 | 0.62 ± 0.25 |
CSF IGF-II | 41 ± 7 | 45 ± 8a |
CSF IGFBP-2 | 122 ± 23 | 136 ± 27a |
CSF IGFBP-3 | 18 ± 6 | 21 ± 8 |
CSF IGF-I/IGFBP-3 | 0.035 ± 0.009 | 0.032 ± 0.009 |
Plasma IGF-I | 99 ± 38 | 92 ± 39 |
Plasma IGF-II | 680 ± 105 | 619 ± 114b |
Plasma IGFBP-2 | 483 ± 234 | 632 ± 354b |
Plasma IGFBP-3 | 2.3 ± 0.65 | 2.0 ± 0.57a |
Plasma IGF-I/IGFBP-3 | 44 ± 19 | 46 ± 20 |